Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death

Heart Rhythm

Volumn 9, Issue 8, 2012, Pages

  Merchant, Faisal M ^a,b   Ikeda, Takanori ^c   Pedretti, Roberto F E ^d   Salerno Uriarte, Jorge A ^e   Chow, Theodore ^f   Chan, Paul S ^g   Bartone, Cheryl ^h   Hohnloser, Stefan H ⁱ   Cohen, Richard J ^j   Armoundas, Antonis A ^b,j  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c TOHO UNIVERSITY   (Japan)

^d IRCCS   (Italy)

^e UNIVERSITY OF INSUBRIA   (Italy)

^f Regional Medical Center of San Jose   (United States)

^g UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^h CHRIST HOSPITAL   (United States)

ⁱ GOETHE UNIVERSITY   (Germany)

^j MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

more..

Author keywords

Arrhythmia; heart failure; ICD; Risk stratification; Sudden cardiac death; T wave alternans

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MICROVOLT T WAVE ALTERNANS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUDDEN DEATH; SURVIVAL PREDICTION; T WAVE;

EID: 84864446744     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2012.03.014     Document Type: Article

References (45)

1. A.J. Moss, W. Zareba, W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
2. G.H. Bardy, K.L. Lee, D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
3. F.M. Merchant, A.A. Armoundas Role of substrate and triggers in the genesis of cardiac alternans, from the myocyte to the whole heart: implications for therapy Circulation 125 2012 539 549
4. M.R. Reynolds, D.J. Cohen, A.D. Kugelmass The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators J Am Coll Cardiol 47 2006 2493 2497
5. L.W. Stevenson Projecting heart failure into bankruptcy in Am Heart J 161 2012 1007 1011
6. D.M. Bloomfield, J.T. Bigger, R.C. Steinman Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction J Am Coll Cardiol 47 2006 456 463
7. S.H. Hohnloser, T. Ikeda, D.M. Bloomfield, O.H. Dabbous, R.J. Cohen T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation Lancet 362 2003 125 126
8. T. Ikeda, H. Yoshino, K. Sugi Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study J Am Coll Cardiol 48 2006 2268 2274
9. J.A. Salerno-Uriarte, G.M. De Ferrari, C. Klersy Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study J Am Coll Cardiol 50 2007 1896 1904
10. S.H. Hohnloser, T. Ikeda, R.J. Cohen Evidence regarding clinical use of microvolt T-wave alternans Heart Rhythm 6 2009 S36 S44
11. K.A. Ellenbogen, J.H. Levine, R.D. Berger Are implantable cardioverter-defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 113 2006 776 782
12. J.J. Germano, M. Reynolds, V. Essebag, M.E. Josephson Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol 97 2006 1255 1261
13. T. Chow, D.J. Kereiakes, C. Bartone Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy J Am Coll Cardiol 49 2007 50 58
14. T. Klingenheben, M. Zabel, R.B. D'Agostino, R.J. Cohen, S.H. Hohnloser Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure [letter] Lancet 356 2000 651 652
15. T. Ikeda, H. Saito, K. Tanno T-wave alternans as a predictor for sudden cardiac death after myocardial infarction Am J Cardiol 89 2002 79 82
16. P.S. Chan, B.K. Nallamothu, J.A. Spertus Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention Circ Cardiovasc Qual Outcomes 2 2009 16 24
17. D.S. Rosenbaum, L.E. Jackson, J.M. Smith Electrical alternans and vulnerability to ventricular arrhythmias N Engl J Med 330 1994 235 241
18. D.M. Bloomfield, S.H. Hohnloser, R.J. Cohen Interpretation and classification of microvolt T wave alternans tests J Cardiovasc Electrophysiol 13 2002 502 512
19. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 2008 e350 e408
20. G.I. Fishman, S.S. Chugh, J.P. Dimarco Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop Circulation 122 2010 2335 2348
21. A.A. Armoundas, S.H. Hohnloser, T. Ikeda, R.J. Cohen Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation? Nat Clin Pract Cardiovasc Med 2 2005 522 528
22. E.C. Stecker, C. Vickers, J. Waltz Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study J Am Coll Cardiol 47 2006 1161 1166
23. D.P. Zipes, A.J. Camm, M. Borggrefe ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Eur Heart J 27 2006 2099 2140
24. E.S. Kaufman, D.M. Bloomfield, R.C. Steinman "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction J Am Coll Cardiol 48 2006 1399 1404
25. P.S. Chan, C. Bartone, T. Booth, D. Kereiakes, T. Chow Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal Am Heart J 153 2007 523 529
26. S.H. Hohnloser, T. Ikeda, R.J. Cohen Evidence regarding clinical use of microvolt T-wave alternans Heart Rhythm 6 Mar 2009 S36 S44
27. M.R. Gold, D.M. Bloomfield, J.M. Anderson A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification J Am Coll Cardiol 36 2000 2247 2253
28. S.H. Hohnloser, T. Klingenheben, D. Bloomfield, O. Dabbous, R.J. Cohen Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study J Am Coll Cardiol 41 June 18 2003 2220 2224
29. E.J. Rashba, A.F. Osman, K. Macmurdy Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease J Cardiovasc Electrophysiol 15 Feb 2004 170 176
30. D.J. Cantillon, K.M. Stein, S.M. Markowitz Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction J Am Coll Cardiol 50 Jul 10 2007 166 173
31. M.R. Gold, J.H. Ip, O. Costantini Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy Circulation 118 Nov 11 2008 2022 2028
32. T. Chow, D.J. Kereiakes, J. Onufer Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial J Am Coll Cardiol 52 Nov 11 2008 1607 1615
33. O. Costantini, S.H. Hohnloser, M.M. Kirk The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention J Am Coll Cardiol 53 Feb 10 2009 471 479
34. J.M. Tapanainen, A.M. Still, K.E.J. Airaksinen, H.V. Huikuri Prognostic significance of risk stratifiers of mortality, including T wave alternans, afer acute myocardial infarction: Results of a propsective follow-up study J Cardiovasc Electrophysiol 12 2001 645 652
35. E.Z. Gorodeski, D.J. Cantillon, S.S. Goel Microvolt T-wave alternans, peak oxygen consumption, and outcome in patients with severely impaired left ventricular systolic function J Heart Lung Transplant 28 Jul 2009 689 696
36. D.M. Bloomfield, J.T. Bigger, R.C. Steinman Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction J Am Coll Cardiol 47 Jan 17 2006 456 463
37. H. Kitamura, Y. Ohnishi, K. Okajima Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy J Am Coll Cardiol 39 2002 295 300
38. W. Grimm, M. Christ, J. Bach, H.H. Muller, B. Maisch Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study Circulation 108 Dec 9 2003 2883 2891
39. P.S. Chan, B.K. Nallamothu, J.A. Spertus Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention Circ Cardiovasc Qual Outcomes 2 Jan 2009 16 24
40. T. Klingenheben, M. Zabel, R.B. D'Agostino, R.J. Cohen, S.H. Hohnloser Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure [letter] Lancet 356 2000 651 652
41. J.A. Salerno-Uriarte, G.M. De Ferrari, C. Klersy Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study J Am Coll Cardiol 50 Nov 6 2007 1896 1904
42. T. Ikeda, H. Saito, K. Tanno T-wave alternans as a predictor for sudden cardiac death after myocardial infarction Am J Cardiol 89 2002 79 82
43. T. Ikeda, H. Yoshino, K. Sugi Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study J Am Coll Cardiol 48 Dec 5 2006 2268 2274
44. D.S. Rosenbaum, L.E. Jackson, J.M. Smith, H. Garan, J.N. Ruskin, R.J. Cohen Electrical alternans and vulnerability to ventricular arrhythmias N Engl J Med 330 1994 235 241
45. D.M. Bloomfield, S.H. Hohnloser, R.J. Cohen Interpretation and classification of microvolt T wave alternans tests J Cardiovasc Electrophysiol 13 May 2002 502 512